These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19782670)

  • 1. Down-regulation of dicer expression in ovarian cancer tissues.
    Pampalakis G; Diamandis EP; Katsaros D; Sotiropoulou G
    Clin Biochem; 2010 Feb; 43(3):324-7. PubMed ID: 19782670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
    Faggad A; Budczies J; Tchernitsa O; Darb-Esfahani S; Sehouli J; Müller BM; Wirtz R; Chekerov R; Weichert W; Sinn B; Mucha C; Elwali NE; Schäfer R; Dietel M; Denkert C
    J Pathol; 2010 Feb; 220(3):382-91. PubMed ID: 19960504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.
    Sand M; Gambichler T; Skrygan M; Sand D; Scola N; Altmeyer P; Bechara FG
    Cancer Invest; 2010 Jul; 28(6):649-53. PubMed ID: 20210522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH-II mRNA expression in tumor tissue and peripheral blood mononuclear cells (PBMCs) in patients with malignant and benign ovarian tumors.
    Serin IS; Tanriverdi F; Ata CD; Akalin H; Ozcelik B; Ozkul Y; Kelestimur F
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):92-6. PubMed ID: 20018426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of silencing Dicer by small interference RNA on the biological characteristics of human glioma cells].
    Zhang AL; Kang CS; Han L; Wang GX; Jia ZF; Pu PY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Oct; 26(5):521-4. PubMed ID: 19806572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dicer and Drosha in ovarian cancer.
    Köbel M; Gilks CB; Huntsman DG
    N Engl J Med; 2009 Mar; 360(11):1150-1; author reply 1151. PubMed ID: 19279349
    [No Abstract]   [Full Text] [Related]  

  • 9. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.
    Chiosea S; Jelezcova E; Chandran U; Acquafondata M; McHale T; Sobol RW; Dhir R
    Am J Pathol; 2006 Nov; 169(5):1812-20. PubMed ID: 17071602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
    Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
    FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Dicer predicts poor survival in colorectal cancer.
    Faber C; Horst D; Hlubek F; Kirchner T
    Eur J Cancer; 2011 Jun; 47(9):1414-9. PubMed ID: 21345667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in mRNA and protein levels of human HtrA1, HtrA2 and HtrA3 in ovarian cancer.
    Narkiewicz J; Klasa-Mazurkiewicz D; Zurawa-Janicka D; Skorko-Glonek J; Emerich J; Lipinska B
    Clin Biochem; 2008 May; 41(7-8):561-9. PubMed ID: 18241672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Dicer and Drosha in triple-negative breast cancer.
    Passon N; Gerometta A; Puppin C; Lavarone E; Puglisi F; Tell G; Di Loreto C; Damante G
    J Clin Pathol; 2012 Apr; 65(4):320-6. PubMed ID: 22259182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dicer and outcomes in patients with acute myeloid leukemia (AML).
    Martin MG; Payton JE; Link DC
    Leuk Res; 2009 Aug; 33(8):e127. PubMed ID: 19278725
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
    Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
    Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinately up-regulated genes in ovarian cancer.
    Hough CD; Cho KR; Zonderman AB; Schwartz DR; Morin PJ
    Cancer Res; 2001 May; 61(10):3869-76. PubMed ID: 11358798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.